載入...
MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL
BACKGROUND: MicroRNAs are known to inhibit gene expression by binding to the 3′UTR of the target transcript. Downregulation of miR-223 has been recently reported to have prognostic significance in CLL. However, there is no evidence of the pathogenetic mechanism of this miRNA in CLL patients. METHODS...
Na minha lista:
發表在: | BMC Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
BioMed Central
2015
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4404064/ https://ncbi.nlm.nih.gov/pubmed/25880332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1212-2 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|